Abstract
Chagas’ disease is one of the most frequent etiology of heart failure in patients submitted to heart transplant in Latin America. Incidence of Chagas cardiomiopathy is also increasing in developed countries. Reactivation of Chagas' disease may occur after transplantation, leading to higher morbidity and graft dysfunction. There is lack of data in incidence of reactivation in the last decade. The aim of this study is to evaluate the incidence of Chagas' disease reactivation on new immunosuppression era.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
